The evidence supporting the classification of variants detected during genomic testing, such as exome sequencing, is constantly accumulating. Additionally, new patient phenotypes may be recognized that impact variant interpretation. Thus, the diagnostic yield of genomic testing may be increased by reevaluation of variant classifications or case-level reanalysis. This session will provide guidance for laboratories seeking to perform reanalysis of genomic testing results.
Guidance for Reevaluation and Reanalysis of Genomic Test Results
Josh Deignan, PhD, University of California - Los Angeles, Los Angeles, CA, USA
Objectives:
- Recognize the considerations surrounding the reevaluation and reanalysis of genomic test results.
- Design and implement strategies for the reevaluation and reanalysis of genomic test results.
Recording Date: November 16, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
